Quest Diagnostics (DGX)
NYSE: DGX
· Real-Time Price · USD
180.33
1.89 (1.06%)
At close: Aug 15, 2025, 2:47 PM
Quest Diagnostics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.52B | 10.16B | 9.87B | 9.54B | 9.35B | 9.29B | 9.25B | 9.3B | 9.49B | 9.6B | 9.88B | 10.29B | 10.58B | 10.68B | 10.79B | 11.05B | 11.06B | 10.34B |
Cost of Revenue | 7.05B | 6.82B | 6.63B | 6.41B | 6.28B | 6.23B | 6.2B | 6.22B | 6.3B | 6.36B | 6.45B | 6.59B | 6.64B | 6.6B | 6.58B | 6.59B | 6.5B | 6.16B |
Gross Profit | 3.48B | 3.34B | 3.24B | 3.13B | 3.07B | 3.06B | 3.06B | 3.08B | 3.19B | 3.24B | 3.43B | 3.7B | 3.94B | 4.08B | 4.21B | 4.45B | 4.55B | 4.17B |
Operating Income | 1.46B | 1.39B | 1.35B | 1.25B | 1.26B | 1.26B | 1.26B | 1.13B | 1.18B | 1.22B | 1.43B | 1.83B | 2.09B | 2.23B | 2.38B | 2.64B | 2.71B | 2.46B |
Interest Income | 21M | 24M | 25M | 24M | 16M | 15M | 11M | 9M | 12M | 12M | 10M | 7M | 3M | 1M | 1M | 1M | 1M | 2M |
Pretax Income | 1.29B | 1.21B | 1.19B | 1.14B | 1.14B | 1.15B | 1.16B | 1.02B | 1.07B | 1.08B | 1.28B | 1.69B | 2.02B | 2.52B | 2.68B | 2.95B | 3.04B | 2.47B |
Net Income | 949M | 897M | 871M | 841M | 840M | 846M | 854M | 763M | 792M | 790M | 942M | 1.23B | 1.48B | 1.87B | 1.99B | 2.17B | 2.24B | 1.79B |
Selling & General & Admin | 1.87B | 1.8B | 1.76B | 1.69B | 1.62B | 1.63B | 1.64B | 1.8B | 1.88B | 1.89B | 1.87B | 1.77B | 1.74B | 1.75B | 1.73B | 1.71B | 1.68B | 1.61B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 144M | 148M | 142M | 182M | 181M | 166M | 158M | 147M | 127M | 131M | 131M | 97M | 110M | 101M | 101M | 102M | 169M | 109M |
Operating Expenses | 2.01B | 1.94B | 1.9B | 1.87B | 1.8B | 1.8B | 1.79B | 1.95B | 2.01B | 2.02B | 2B | 1.87B | 1.85B | 1.85B | 1.83B | 1.81B | 1.85B | 1.72B |
Interest Expense | 269M | 249M | 226M | 200M | 183M | 175M | 163M | 153M | 149M | 148M | 148M | 150M | 151M | 151M | 152M | 154M | 158M | 162M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.06B | 8.77B | 8.53B | 8.29B | 8.08B | 8.03B | 7.99B | 8.17B | 8.31B | 8.38B | 8.46B | 8.46B | 8.49B | 8.45B | 8.41B | 8.41B | 8.35B | 7.88B |
Income Tax Expense | 289M | 266M | 273M | 245M | 248M | 249M | 248M | 204M | 217M | 219M | 264M | 382M | 454M | 554M | 597M | 674M | 698M | 587M |
Shares Outstanding (Basic) | 112M | 111M | 111M | 112M | 111M | 111M | 112M | 112M | 112M | 112M | 113M | 116M | 117M | 119M | 122M | 123M | 125M | 133M |
Shares Outstanding (Diluted) | 113M | 113M | 113M | 113M | 112M | 112M | 113M | 114M | 114M | 113M | 115M | 118M | 119M | 121M | 125M | 125M | 127M | 135M |
EPS (Basic) | 8.47 | 8.01 | 7.78 | 7.52 | 7.50 | 7.54 | 7.59 | 6.76 | 6.96 | 6.86 | 8.04 | 10.34 | 12.26 | 15.32 | 15.87 | 16.96 | 17.05 | 13.38 |
EPS (Diluted) | 8.35 | 7.92 | 7.70 | 7.45 | 7.42 | 7.43 | 7.49 | 6.67 | 6.86 | 6.77 | 7.92 | 10.16 | 12.03 | 15.03 | 15.56 | 16.65 | 16.77 | 13.17 |
EBITDA | 1.93B | 1.95B | 1.9B | 1.78B | 1.75B | 1.74B | 1.73B | 1.6B | 1.65B | 1.64B | 1.82B | 2.2B | 2.5B | 2.99B | 3.16B | 3.41B | 3.5B | 2.93B |
EBIT | 1.52B | 1.43B | 1.4B | 1.31B | 1.3B | 1.29B | 1.29B | 1.16B | 1.2B | 1.21B | 1.38B | 1.78B | 2.08B | 2.58B | 2.75B | 3.01B | 3.11B | 2.55B |
Depreciation & Amortization | 400M | 517M | 493M | 467M | 453M | 448M | 439M | 446M | 443M | 438M | 437M | 427M | 420M | 413M | 408M | 400M | 388M | 377M |